Bryan T Baldasare Meridian Bioscience Inc (VIVO) insider trading activity

Bryan T Baldasare is Exec VP & CFO of MERIDIAN BIOSCIENCE INC. Currently has a direct ownership of 60,929 shares of VIVO, which is worth approximately $0. The most recent transaction as insider was on Dec 15, 2021, when has been sold 1,985 shares (Common Stock) at a price of $17.92 per share, resulting in proceeds of $35,571. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 60.9K

0% 3M change

0% 12M change

Total Value Held $0

Bryan T Baldasare Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 15 2021	SELL Payment of exercise price or tax liability	$35,571 $17.92 p/Share	1,985 Reduced 3.16%	60,929 Common Stock
Nov 15 2021	SELL Payment of exercise price or tax liability	$76,749 $20.16 p/Share	3,807 Reduced 5.71%	62,914 Common Stock
Nov 15 2021	SELL Other acquisition or disposition	-	32,557 Reduced 48.8%	34,164 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	-	32,557 Added 32.79%	66,721 Common Stock
Nov 04 2021	BUY Grant, award, or other acquisition	-	10,593 Added 13.7%	66,721 Common Stock
Feb 08 2021	SELL Open market or private sale	$187,620 $30.0 p/Share	6,254 Reduced 10.03%	56,128 Common Stock
Feb 08 2021	BUY Exercise of conversion of derivative security	$73,350 $19.56 p/Share	3,750 Added 5.67%	62,382 Common Stock
Feb 05 2021	SELL Open market or private sale	$379,193 $26.61 p/Share	14,250 Reduced 19.55%	58,632 Common Stock
Feb 05 2021	BUY Exercise of conversion of derivative security	$220,050 $19.56 p/Share	11,250 Added 13.37%	72,882 Common Stock
Nov 16 2020	SELL Payment of exercise price or tax liability	$34,066 $17.11 p/Share	1,991 Reduced 3.13%	61,632 Common Stock
Nov 05 2020	BUY Grant, award, or other acquisition	-	10,823 Added 14.54%	63,623 Common Stock

Also insider at

INM

InMed Pharmaceuticals Inc. Healthcare

Director

BTB